Prospective cohort study of HCV infection and the risk of developement of maligant lymphoma
Not Applicable
- Conditions
- hematopoietic malignancy
- Registration Number
- JPRN-UMIN000003652
- Lead Sponsor
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
not specified
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The difference of the ratio of HCV infected population between malignant lymphoma and other hematopoietic malignancies.
- Secondary Outcome Measures
Name Time Method The difference of HCV genotype between malignant lymphoma and other hematopoietic malignancies.